Close

Citi Downgrades Genzyme (GENZ) to Hold, Citing Lack of Visibility

March 3, 2009 8:33 AM EST Send to a Friend
Citi downgrades Genzyme Corp (Nasdaq: GENZ) from Buy to Hold. Price target lowered from $81 to $61.

Citi ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login